Ldpe In Medical And Hygiene Products Grade And Compliance Requirements
Within the medical flexible-packaging supply chain, LDPE is specified less by nominal resin class than by tight lot-to-lot consistency in density, melt flow rate, catalyst residue, additive composition, and gel content. A film-grade resin for ethylene oxide or radiation-sterilized pouch and lidding applications typically shows density of 0.918–0.925 g/cm³ under ISO 1183-1 and melt flow rate of 1.0–4.0 g/10 min at 190 °C and 2.16 kg load under ISO 1133-1. Converters running high-output cast film with 90 mm barrier screws and deckle-adjustable dies require resin with an antioxidant package that does not form phenolic odour bodies during prolonged residence time at melt temperatures above 220 °C. Supplier control typically documents trace metal content below 10 mg/kg and ash content below 50 mg/kg for pharmaceutical-grade lots, because residues become extractables in the final sterile barrier system.
The film is usually processed without external lubricants that could interfere with subsequent flexographic or gravure printing. If slip and antiblock are required, only non-migrating or low-migration grades of erucamide, oleamide, silica, or zeolite are permitted at loadings below 0.3 wt%. On blown-film lines, a spiral mandrel die with a 1.8–2.2 mm die gap and blow-up ratio of 2.2:1–2.8:1 is used to balance dart impact and tear resistance; cast-film lines with roll temperatures below 18 °C maximize gloss and minimize haze for optical inspection of packaged devices.
What Distinguishes a Clean-Peel Medical LDPE from General-Purpose Extrusion Film?
The segregation point is not polymer density but additive selection and surface rheology needed for controlled seal separation. General-purpose LDPE film sealed at high temperature often fails in cohesive or string-peel mode, whereas medical lidding film is engineered for a clean, consistent peel at 50–80 N/m seal strength measured by ASTM F88/F88M-21 across 15 mm wide specimens. The clean-peel mechanism is achieved by blending LDPE with polyolefin plastomers or EVA in the sealant layer at 10–25 wt%, but EVA concentrations above 25 wt% reduce the 1% secant modulus from roughly 200 MPa to below 120 MPa when tested per ISO 527-3, producing a film that cannot maintain die-cut shape stability on high-speed pouch machines.
Another differentiator is particulate cleanliness. Optical gel inspection systems on cast lines frequently reject general-purpose lots with gel counts above 100 defects per square metre. For medical cameras that inspect filled pouches through the LDPE web at 200 lux, even smaller gel bodies can generate false rejects. Therefore, suppliers of medical LDPE specify gel-free performance using in-line cameras calibrated to detect dark specks larger than 0.3 mm. The film also must maintain controlled slip without creating haze above 12% per ASTM D1003 and must not exceed 60 gloss units as measured by ASTM D2457; this keeps downstream label placement robust while preserving visual clarity.
| Parameter | Test method | Medical blown-film grade | Hygiene extrusion lamination grade |
|---|---|---|---|
| Density | ISO 1183-1 | 0.918–0.925 g/cm³ | 0.915–0.925 g/cm³ |
| Melt flow rate | ISO 1133-1 | 1.0–4.0 g/10 min | 4.0–8.0 g/10 min |
| Tensile elongation at break, MD | ASTM D882 | 300–500% | 200–400% |
| Seal initiation temperature | ASTM F1921 | 85–105 °C | 95–115 °C |
| Water vapour transmission rate, 50 µm | ASTM E96/E96M | 5–8 g/m²·day | 6–10 g/m²·day |
If the Sealant Layer Must Survive Ethylene Oxide and Gamma Sterilization, Thermal History Dominates
Sterilization mode forces divergent product requirements. Ethylene oxide sterilisation exposes LDPE to 45–60 °C gas at elevated relative humidity for 2–6 h, followed by aeration; this temperature is below LDPE’s Vicat softening temperature of 90–100 °C under ISO 306/A50, so heat-seal integrity survives. Gamma irradiation at 25–50 kGy generates free radicals; in LDPE the dominant effect is crosslinking with a progressive reduction in ultimate elongation and tear propagation. A film that starts with tensile elongation at break above 400% in the machine direction per ASTM D882 may retain only 200–300% after 50 kGy; published data for specific formulation variants is limited. Therefore, radiation-stable grades use hindered amine stabilisers and avoid unsaturated additives that accelerate chain scission.
Process window conflict appears during sealant coextrusion. Adding EVA or polyolefin plastomer to reduce seal initiation temperature to 85–100 °C also lowers the film’s autoclave tolerance. At 121 °C moist heat, the seal layer softens sufficiently to distort or seal to the device package insert. Consequently, LDPE-only sterile barrier films are generally not assigned to autoclave terminal sterilisation; suppliers specify the upper continuous-use temperature as 60–80 °C based on seal-strength retention after simulated transport. High-speed form-fill-seal lines impose hot-tack requirements. Hot tack measured per ASTM F1921 must remain above 0.5 N/15 mm during seal cooling from 110 °C to 40 °C; failing this, seal creep opens the pouch before product insertion.
In hygiene backsheet and nonwoven lamination, LDPE is extruded as a molten tie layer between a polypropylene nonwoven and a polyethylene film at line speeds from 200–400 m/min. A single-screw extruder with a 30:1 L/D barrier screw and gear pump delivers melt to a flat die at 290–320 °C; the elevated melt temperature is deliberately used to generate polar oxidation products on the LDPE melt surface, improving adhesion to the nonwoven without solvent-based primers. However, melt temperature above 330 °C causes low-molecular-weight oxidation volatiles, increasing odour and extractable content, which is a batch rejection point for hygiene producers using sensory panels calibrated to 5 µg/g condensate thresholds. Adhesion is measured by 90° peel on a tensile tester at 300 mm/min; acceptable nonwoven-to-film bond values for an 18 g/m² LDPE coating over 15 g/m² spunbond nonwoven are generally above 0.8 N/25 mm.
Melt-Flow Windows and Bacterial Barrier Trade-Offs in High-Speed FFS Lines
The form-fill-seal process for unit-dose physiological saline or alcohol wipes uses LDPE at 0.8–1.5 g/10 min for blown film to preserve bubble stability; however, seal-bar productivity falls if melt flow rate is below 0.8 g/10 min because limited melt flow prevents complete interfacial wetting at seal pressures below 0.4 MPa. Raising melt flow rate to 4.0 g/10 min improves seal throughput but reduces machine-direction Elmendorf tear strength from 25–35 N/mm to below 18 N/mm per ASTM D1922, making the pouch prone to notch propagation during rotary knife slitting.
Bacterial barrier remains a design-critical requirement under ISO 11607-1:2019 clause 5.2.5; LDPE film thickness below 40 µm is rarely used for direct microbial barrier unless supported by a nonwoven or paper layer. Standard LDPE grades are not inherently high gas or water vapour barriers; water vapour transmission rate for a 50 µm film is approximately 5–8 g/m²·day at 38 °C and 90% RH per ASTM E96/E96M. For hygroscopic devices, coextruded LDPE/tie/EVOH/tie/LDPE structures are used, with LDPE serving as moisture sealant surfaces, not oxygen barrier.
The Skin-Contact Compliance File Is Split Between Polymer, Device, and Package
For LDPE in medical and hygiene applications, the compliance file is split between polymer safety, device endpoint, and packaging. The polymer itself is covered by FDA 21 CFR 177.1520, which permits olefin polymers for food-contact use under specific density and additive restrictions. A medical device manufacturer may still use this listing as a raw-material screen, but direct patient-contact LDPE components are evaluated under ISO 10993-1:2018, with endpoints selected from Annex A based on contact duration and tissue type. Short-term skin-contact films are tested for cytotoxicity via ISO 10993-5, sensitisation via ISO 10993-10, and irritation via ISO 10993-23; long-term implant applications are generally outside LDPE’s intended use.
In the European Union, LDPE used in medical device housings or packaging must be REACH compliant; the supplier declaration typically confirms no substance of very high concern exceeds 0.1% w/w. RoHS Directive 2011/65/EU applies to electronic medical devices, with lead, mercury, cadmium, hexavalent chromium, PBB, PBDE, and four phthalates each limited to 0.1% w/w; LDPE containing no halogenated flame retardants can meet the standard. For hygiene products such as diaper backsheets, skin-contact extracts are screened against the same irritation and sensitisation methods, while EU Regulation (EU) No 10/2011 is used as a benchmark for overall migration when the material is used adjacent to food in training pads or changing mats.
| Requirement | Standard / code | Parameter | Typical acceptance criterion |
|---|---|---|---|
| Cytotoxicity | ISO 10993-5 | L929 cell viability | Not less than 70% of blank |
| Sensitisation | ISO 10993-10 | Dermal sensitisation grade | No greater than control |
| Irritation | ISO 10993-23 | Dermal irritation index | No persistent erythema or oedema |
| Overall migration | EU 10/2011 | Migration into simulant | ≤10 mg/dm² |
| RoHS restricted substances | 2011/65/EU | Phthalates and heavy metals | ≤0.1% w/w per substance |
| REACH SVHC screening | REACH Article 33 | Substance concentration | ≤0.1% w/w per SVHC |
For ethylene oxide sterilisation compatibility, LDPE films must show no measurable surface reactivity with EO gas and no residual ethylene chlorohydrin above the device manufacturer’s validated limit, typically below 10 µg/g after aeration. The same material may fail this requirement if nitrogen-containing antistatic additives are present, because ethylene glycol derivatives can form chlorohydrin residues. Therefore, the additive package is locked at the resin supplier and changes require requalification under ISO 11607-1:2019 packaging validation protocols.